Acute Myeloid Leukemia Patient

Circulating exosomes carrying an immunosuppressive cargo may interfere with adoptive cell therapies in leukemia
Michael Boyiadzis, Chang-Sook Hong, Theresa L Whiteside

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P60; DOI: 10.1186/2051-1426-3-S2-P60
Next-generation dendritic cells for immunotherapy of acute myeloid leukemia
Frauke Schnorfeil, Felix Lichtenegger, Christiane Geiger, Thomas Köhnke, Veit Bücklein, Torben Altmann, Beate Wagner, Reinhard Henschler, Iris Bigalke, Gunnar Kvalheim, Wolfgang Hiddemann, Dolores Schendel, Marion Subklewe

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P84; DOI: 10.1186/2051-1426-2-S3-P84
Activation of the STING pathway enhances immunity and improves survival in a murine myeloid leukemia model
Emily Curran, Xiufen Chen, Leticia Corrales, Justin Kline

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P166; DOI: 10.1186/2051-1426-2-S3-P166
Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study
Tanja de Gruijl, Saskia Santegoeds, Sandra van Wetering, Satwinder Kaur Singh, Anthony Hall, Arjan A van de Loosdrecht, Ada Kruisbeek

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P205; DOI: 10.1186/2051-1426-1-S1-P205
P20. Lack of T cell exhaustion in acute myeloid leukaemia
FM Schnorfeil, FS Lichtenegger, K Emmerig, M Schlüter, R Draenert, W Hiddemann, M Subklewe

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) P11; DOI: 10.1186/2051-1426-2-S2-P11

Log in using your username and password

Main menu

Log in using your username and password

You are here

Acute Myeloid Leukemia Patient